Moschen, Alexander R.
Innsbruck Medical University · Universität Innsbruck
17 papers on CoChatORCID 0000-0003-3598-7848
Most cited papers
- Verified
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 2,548
- Verified
NAFLD and diabetes mellitus
Tilg, H., Moschen, A. R., & Roden, M. (2017) · Nature Reviews Gastroenterology & Hepatology
Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 1,002
- Verified
Microbiota and diabetes: an evolving relationship
Tilg, H., & Moschen, A. R. (2014) · Gut
Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases
Cited by 853
- Verified
Inflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine
Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism
Cited by 779
- Verified
The Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell
Gut microbiota and healthColorectal Cancer Treatments and Studies
Cited by 777
- Verified
Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease
Grander, C., Adolph, T. E., Wieser, V., Lowe, P., Wrzosek, L., Gyongyosi, B., Ward, D. V., Grabherr, F., Gerner, R. R., Pfister, A., et al. (2018) · Gut
Gut microbiota and healthAlcohol Consumption and Health Effects
Cited by 618
- Verified
Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction
Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 482
- Verified
Lipocalin 2 protects from inflammation and Tumorigenesis associated with gut microbiota alterations
Moschen, A. R., Gerner, R. R., Wang, J., Klepsch, V., Adolph, T. E., Reider, S. J., Hackl, H., Pfister, A., Schilling, J., Moser, P. L., et al. (2016) · Cell Host & Microbe
Gut microbiota and healthInflammatory Bowel Disease
Cited by 375
- Verified
Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation
Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V., & Tilg, H. (2017) · Trends in Endocrinology & Metabolism
Adipokines, Inflammation, and Metabolic DiseasesInflammation biomarkers and pathways
Cited by 359
- Verified
Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease
Mayr, L., Grabherr, F., Schwärzler, J., Reitmeier, I., Sommer, F., Gehmacher, T., Niederreiter, L., He, G.-W., Ruder, B., Kunz, K. T. R., et al. (2020) · Nature Communications
Inflammatory Bowel DiseaseGut microbiota and health
Cited by 292
- Verified
Food, immunity, and the microbiome
Tilg, H., & Moschen, A. R. (2015) · Gastroenterology
Gut microbiota and healthNutritional Studies and Diet
Cited by 292
- Verified
Gut, inflammation and osteoporosis: Basic and clinical concepts
Tilg, H., Moschen, A. R., Kaser, A., Pines, A., & Dotan, I. (2008) · Gut
Bone Metabolism and DiseasesInflammatory Bowel Disease
Cited by 292
- Verified
Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways
Nairz, M., Schroll, A., Moschen, A. R., Sonnweber, T., Theurl, M., Theurl, I., Taub, N., Jamnig, C., Neurauter, D., Huber, L. A., et al. (2011) · Immunity
Erythropoietin and Anemia TreatmentNF-κB Signaling Pathways
Cited by 194
- Verified
NAD metabolism fuels human and mouse intestinal inflammation
Gerner, R. R., Klepsch, V., Macheiner, S., Arnhard, K., Adolph, T. E., Grander, C., Wieser, V., Pfister, A., Moser, P., Hermann-Kleiter, N., et al. (2018) · Gut
Sirtuins and Resveratrol in MedicineInflammatory Bowel Disease
Cited by 192
- Verified
Dietary Factors: Major Regulators of the Gut's Microbiota
Moschen, A. R., Wieser, V., & Tilg, H. (2012) · Gut and Liver
Gut microbiota and healthNutritional Studies and Diet
Cited by 173
- Verified
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study
Zollner, A., Schmiderer, A., Reider, S. J., Oberhuber, G., Pfister, A., Texler, B., Watschinger, C., Koch, R., Effenberger, M., Raine, T., et al. (2021) · Journal of Crohn's and Colitis
Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome
Cited by 95
- Verified
Lipocalin‐2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response
Nairz, M., Schroll, A., Haschka, D., Dichtl, S., Sonnweber, T., Theurl, I., Theurl, M., Lindner, E., Demetz, E., Aßhoff, M., et al. (2015) · European Journal of Immunology
Immune Response and InflammationIron Metabolism and Disorders
Cited by 67
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free